Kynam Capital Management, LP Caribou Biosciences, Inc. Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
A detailed history of Kynam Capital Management, LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 3,067,774 shares of CRBU stock, worth $7.64 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
3,067,774
Previous 3,269,147
6.16%
Holding current value
$7.64 Million
Previous $2.97 Million
29.96%
% of portfolio
0.46%
Previous 0.25%
Shares
6 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
43.9MCall Options Held
25KPut Options Held
53.2K-
Black Rock Inc. New York, NY6.95MShares$17.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$10.2 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.27MShares$5.66 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$4.51 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.55MShares$3.86 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $151M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...